Malaria breakthrough despite chlorproguanil chemoprophylaxis in an area without antifol resistance.
Petersen
E
E
Malaria Research Unit Liberian Institute for Biomedical Research, Yekepa.
Høgh
B
B
Hanson
A P
AP
Flachs
H
H
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D004351:Drug Resistance; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D008288:Malaria / Q000378:metabolism / Q000517:prevention & control*; D010963:Plasmodium falciparum / Q000187:drug effects; D002727:Proguanil / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D014227:Triazines
D000962:Antimalarials; D005493:Folic Acid Antagonists; D014227:Triazines; C026009:cycloguanil; C007030:chlorproguanil; D002727:Proguanil